SF
BIO icon

Synovus Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Synovus Financial’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-419
Closed -$313K – 856
2021
Q3 		$313K Sell
419
-382
-48% -$286K ﹤0.01% 714
2021
Q2 		$523K Buy
+801
New +$488K 0.01% 601
2021
Q1 		– Sell
-727
Closed -$433K – 746
2020
Q4 		$433K Sell
727
-905
-55% -$515K 0.01% 575
2020
Q3 		$858K Buy
1,632
+53
+3% +$26.8K 0.01% 370
2020
Q2 		$712K Sell
1,579
-587
-27% -$259K 0.01% 390
2020
Q1 		$761K Buy
2,166
+339
+19% +$125K 0.01% 416
2019
Q4 		$673K Sell
1,827
-27
-1% -$9.52K 0.01% 403
2019
Q3 		$617K Sell
1,854
-1,471
-44% -$480K 0.01% 415
2019
Q2 		$1.04M Buy
3,325
+21
+0.6% +$6.29K 0.02% 328
2019
Q1 		$1.01M Buy
3,304
+511
+18% +$138K 0.02% 329
2018
Q4 		$651K Sell
2,793
-9
-0.3% -$2.42K 0.01% 380
2018
Q3 		$876K Buy
2,802
+41
+1% +$12.7K 0.01% 349
2018
Q2 		$797K Buy
2,761
+1,087
+65% +$300K 0.01% 355
2018
Q1 		$433K Buy
1,674
+704
+73% +$179K 0.01% 453
2017
Q4 		$233K Buy
970
+4
+0.4% +$969 ﹤0.01% 539
2017
Q3 		$222K Buy
966
+67
+7% +$15.1K ﹤0.01% 533
2017
Q2 		$209K Buy
899
+287
+47% +$62.5K ﹤0.01% 573
2017
Q1 		$123K Buy
612
+166
+37% +$32K ﹤0.01% 597
2016
Q4 		$78K Buy
+446
New +$76K ﹤0.01% 657

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Synovus Financial's BIO Position: Q4 2021 in Review

Synovus Financial sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 419 shares — an estimated $313K sold.

Synovus Financial first reported a position in BIO in Q4 2016 and held it in 19 quarters. The position peaked at $1.04M in Q2 2019. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Synovus Financial reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Synovus Financial sold 419 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $313K.
  • Synovus Financial first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 19 quarters.
  • Synovus Financial's Bio-Rad Laboratories Class A position peaked at $1.04M in Q2 2019.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Synovus Financial's 13F filing for Q4 2021, filed 14 Feb 2022.